Milsom J W, Hammerhofer K A
Cleveland Clinic Foundation, Ohio, USA.
Oncology (Williston Park). 1995 May;9(5):393-8; discussion 398-9, 403-4, 409.
Laparoscopic intestinal resection is a relatively new application of endoscopic technology that has evolved as a direct result of the successes and benefits seen with laparoscopic gallbladder surgery. Currently acceptable and feasible laparoscopic intestinal resections include those for diagnostic procedures, fecal diversion, Crohn's disease, diverticulitis, familial polyposis, rectal prolapse, and palliative colorectal cancer surgery. However, the efficacy of laparoscopic resection for curative cancer surgery remains a topic of much debate. Issues surrounding curative laparoscopic oncologic resection include the ability to perform an acceptable oncologic resection, the question of morbidity and mortality compared to conventional surgery, and the problem of port site recurrences. Thus, at present, curative laparoscopic oncologic surgery must be conducted within the framework of a prospective, randomized clinical trial, which includes full informed patient consent.
腹腔镜肠切除术是内镜技术的一种相对较新的应用，它是随着腹腔镜胆囊手术取得的成功和益处而直接发展起来的。目前可接受且可行的腹腔镜肠切除术包括用于诊断程序、粪便转流、克罗恩病、憩室炎、家族性息肉病、直肠脱垂以及结直肠癌姑息性手术的那些术式。然而，腹腔镜切除术用于根治性癌症手术的疗效仍是一个备受争议的话题。围绕根治性腹腔镜肿瘤切除术的问题包括能否进行可接受的肿瘤切除术、与传统手术相比的发病率和死亡率问题以及切口部位复发问题。因此，目前，根治性腹腔镜肿瘤手术必须在一项前瞻性、随机临床试验的框架内进行，该试验包括患者的充分知情同意。
